Association of salivary levels of immunoglobulin-a and amylase with oral-dental manifestations in patients with controlled and non-controlled type 2 diabetes

被引：0
|
作者：
Marjan Kheirmand Parizi
Hamed Akbari
Mahsa Malek-mohamadi
Maryam Kheirmand Parizi
Shahla Kakoei
机构：
[1] Kerman University of Medical Sciences,Dentist, Student Research Committee, School of Dentistry
[2] Kerman University of Medical Sciences,Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences
[3] Kerman University of Medical Sciences,Department of Biochemistry, School of Medicine
[4] Shahid Beheshti University of Medical Sciences,Community Oral Health Department, School of dentistry
[5] Shahid Beheshti University of Medical Sciences,Student Research Committee
[6] Dental School,Oral and Dental Diseases Research Center
[7] Kerman University of Medical Sciences,Department of Oral Medicine, School of Dentistry
[8] Kerman University of Medical Sciences,undefined
来源：
BMC Oral Health | / 19卷
关键词：
Diabetes mellitus; Saliva; Salivary immunoglobulin-a; Salivary amylase; Oral manifestations;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Association of salivary levels of immunoglobulin-a and amylase with oral-dental manifestations in patients with controlled and non-controlled type 2 diabetes
    Parizi, Marjan Kheirmand
    Akbari, Hamed
    Malek-mohamadi, Mahsa
    Parizi, Maryam Kheirmand
    Kakoei, Shahla
    BMC ORAL HEALTH, 2019, 19 (01)
  • [2] COMPARING SERUM LEPTIN AND ADIPONECTIN LEVELS IN CONTROLLED AND NON-CONTROLLED TYPE 2 DIABETES
    Farahnak, Zahra
    DJalali, Mahmoud
    Hosseinzadeh, Mohammad Javad
    Eshragheian, Mohammad Reza
    ARYA ATHEROSCLEROSIS, 2007, 3 (03) : 135 - 138
  • [3] Pathologies of the oral cavity in patients with non-controlled diabetes type 1 and type 2-analysis of periodontal status and periodontal treatment needs
    Preferansow, Ewa
    Sawczuk, Beata
    Golebiewska, Maria
    Gorska, Maria
    ENDOKRYNOLOGIA POLSKA, 2015, 66 (05) : 428 - 433
  • [4] Effectiveness and security of use of Sitagliptin in addition to an ongoing treatment by metformin in patients with non-controlled type 2 diabetes by metformin in monotherapy
    Charbonnel, B.
    Valensi, P.
    Giral, P.
    DIABETES & METABOLISM, 2007, 33 : S18 - S18
  • [5] A randomized controlled trial of an educational intervention to promote oral and dental health of patients with type 2 diabetes mellitus
    Malekmahmoodi, Maryam
    Shamsi, Mohsen
    Roozbahani, Nasrin
    Moradzadeh, Rahmatollah
    BMC PUBLIC HEALTH, 2020, 20 (01)
  • [6] A randomized controlled trial of an educational intervention to promote oral and dental health of patients with type 2 diabetes mellitus
    Maryam Malekmahmoodi
    Mohsen Shamsi
    Nasrin Roozbahani
    Rahmatollah Moradzadeh
    BMC Public Health, 20
  • [7] Provability of controlled LDL levels in patients with type 2 diabetes mellitus
    Echevarria, Marines Castillo
    Schmitt, Jessica
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (SUPPL 3): : 104 - 105
  • [8] Type 2 diabetes: introduction and follow-up of insulin therapy by slow analog in 2541 patients with non-controlled type 2 diabetes by oral antidiabetics in a general medicine and diabetology consultation. LIGHT study
    Verges, B.
    Brun, J. M.
    Kerlan, V.
    Tawil, C.
    Leutenegger, E.
    Alexandre, B.
    Gonbert, S.
    DIABETES & METABOLISM, 2009, 35 : A51 - A51
  • [9] Status of Serum and Salivary Levels of Superoxide Dismutase in Type 2 Diabetes Mellitus with Oral Manifestations: A Case Control Study
    Madi, Medhini
    Babu, Subhas
    Kumari, Suchetha
    Shetty, Shishir
    Achalli, Sonika
    Madiyal, Ananya
    Bhat, Manohar
    ETHIOPIAN JOURNAL OF HEALTH SCIENCES, 2016, 26 (06) : 523 - 532
  • [10] Evaluation of the effects of nateglinide on postprandial glycemia in patients with type 2 diabetes mellitus:: A multicenter, multinational, non-randomized, non-controlled Latin American study
    Islas-Andrade, S
    Revilla-Monsalve, MC
    de Hurtado, EM
    Chacín, LF
    Caminos, QR
    Yupanqui, H
    López, G
    de la Torre, W
    PHARMACOLOGY, 2003, 68 (02) : 89 - 95
12345